https://www.selleckchem.com/pr....oducts/guanosine-5-t
I. Beta-blockers were prescribed to 85%, angiotensin-converting enzyme inhibitors to 71%, and loop diuretics to 50% of the patients, respectively. Freedom from the composite endpoint was 100% after 30 days and 88% after 2 years. CONCLUSIONS The survival after LVAD explantation is excellent without the need for heart transplantation or LVAD reimplantation. Only a minority of the patients suffer from a relapse of significant HF. © 2020 The Authors. ESC Heart Failure published by John Wiley Sons Ltd on
Like
Comment
Share
